COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis-Reference-Cited by-同舟云学术

COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis

Published:2022-01 Issue: Volume:57 Page:103359
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Barzegar Mahdi,Mirmosayyeb Omid,Ebrahimi Narges,Bagherieh Sara,Afshari-Safavi Alireza,Hosseinabadi Ali Mahdi,Shaygannejad Vahid,Asgari Nasrin

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference83 articles.

1. Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica;Ajmera;J. Neurol. Sci.,2018

2. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis;Akiyama;Ann. Rheum. Dis.,2021

3. COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM;Alonso;Mult. Scler. Relat. Disord.,2021

4. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy;Apostolidis;Nat. Med.,2021

5. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study;Avouac;Lancet Rheumatol.,2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case Report and Literature Review of a Triple-Vaccinated, Rituximab-Treated Systemic Lupus Erythematosus patient with COVID-19 pneumonia;ARP Rheumatology;2024-06-30

2. Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder;Multiple Sclerosis and Related Disorders;2024-05

3. Immunosuppressive therapy and COVID‐19 infection in patients with NMOSD;Immunity, Inflammation and Disease;2024-01

4. Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study;Frontiers in Immunology;2023-12-04

5. Recontextualizing Neuromyelitis Optica as a Systemic Condition: A Perspective;Journal of Clinical & Translational Ophthalmology;2023-05-24